ADAP

Adaptimmune Therapeutics
ADAP

Overview Fund Activity

92 hedge funds and large institutions have $577M invested in Adaptimmune Therapeutics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 7 closing their positions.

Holders
92
Holders Change
+10
Holders Change %
+12.2%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
30
Reduced
23
Closed
7
Calls
$2.49M
Puts
$1.96M
Net Calls
+$531K
Net Calls Change
+$530K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$13.9M
2
Marshall Wace
2
Marshall Wace
United Kingdom
$8.03M
3
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$66.3M
4
PHS
4
PFM Health Sciences
California
$22.8M
5
Bank of America
5
Bank of America
North Carolina
$3.79M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$394K
2
Morgan Stanley
2
Morgan Stanley
New York
$1.73M
3
ACA
3
Avoro Capital Advisors
New York
$0
4
Capital International Investors
4
Capital International Investors
California
$0
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$312K
Name Market Value Shares Shares
Change 		Shares
Change %
HT
101
HAP Trading
New York
– – – –
1 2 3 4
5